BDBM50030711 CHEMBL338027::L-163958::Pentanoic acid {4-bromo-3-[3-ethyl-4-(3-fluoro-2'-(N-t-butyloxycarbonyl)-Sulfanamido-biphenyl-4-ylmethyl)-5-oxo-4,5-dihydro-[1,2,4]triazol-1-yl]-phenyl}-amide::Pentanoic acid {4-bromo-3-[3-ethyl-4-(3-fluoro-2'-tert-butyloxycarbonylsulfamoyl-biphenyl-4-ylmethyl)-5-oxo-45-dihydro-[124]triazol-1-yl]-phenyl}-amide(L-163958)

SMILES CCCCC(=O)Nc1ccc(Br)c(c1)-n1nc(CC)n(Cc2ccc(cc2F)-c2ccccc2S(=O)(=O)NC(=O)OC(C)(C)C)c1=O

InChI Key InChIKey=TVHACRDUPFKWBO-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50030711   

TargetType-1 angiotensin II receptor(RABBIT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.160nMAssay Description:In vitro inhibitory activity against Angiotensin II receptor, type 1 in rabbit aorta membrane preparations.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-2 angiotensin II receptor(RAT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.210nMAssay Description:In vitro inhibitory activity against angiotensin II type 2 receptor in rat adrenal membrane preparations.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  3.40nMAssay Description:In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-2 angiotensin II receptor(RAT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.120nMAssay Description:In vitro inhibitory activity against Angiotensin II receptor, type 2 in rat midbrain membrane preparations.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-1 angiotensin II receptor(RABBIT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.160nMAssay Description:Antagonist activity at Oryctolagus cuniculus (rabbit) aortic AT1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.120nMAssay Description:Inhibition of Angiotensin II receptor, type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-1 angiotensin II receptor(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of Angiotensin II receptor, type 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetType-1 angiotensin II receptor(RABBIT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  0.160nMAssay Description:Antagonist activity at Oryctolagus cuniculus (rabbit) aortic AT1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
TargetType-1 angiotensin II receptor(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50030711(CHEMBL338027 | L-163958 | Pentanoic acid {4-bromo-...)
Affinity DataIC50:  3.5nMAssay Description:In vitro inhibitory activity against angiotensin II receptor type 1, in human adrenal membrane preparations.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed